Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb tirasemtiv versus placebo in amyotrophic lateral sclerosis
2012-004987-23Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Tirasemtiv with Placebo (2 arms). Primary endpoint: Change from baseline to the average of ALSFRS-R total score at Visits 6 and 7. Started Nov 2012; status: completed.
02
Drugs
tirasemtiv
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2012-004987-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004987-23.